Skip to content
AnalystLens

Markel Group Annual Report, Year Ended Dec 31, 2014

Filing Date
Filed February 27, 2015
Period End
December 31, 2014
Security
MKL
In the record · 2016–202610-K1110-Q338-K100

MKL filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 100 current reports (8-K) between 2016 and 2026.

  1. FY2015 annual report10-K · Feb ’16Feb ’16
  2. Material agreement8-K · Apr ’19Apr ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Leadership change8-K · May ’25May ’25

Summary

Summary of the 10-K filed February 27, 2015. Cited figures are marked; the original filing is the authoritative source.

Markel Corporation, now Markel Group Inc., is a diverse financial holding company that underwrites specialty insurance products in niche markets and also owns industrial and service businesses through its wholly-owned subsidiary Markel Ventures, Inc. For 2014, the company reported earned premiums of $3.84 billiona, net income to shareholders of $321.2 million (up from $281.0 million in 2013), and a U.S. GAAP combined ratio of 95%, compared with 97% in 2013.

Gross premium volume rose to $4.81 billionb from $3.92 billion, largely reflecting the May 2013 acquisition of Alterra Capital Holdings Limited and the inclusion of its premiums for a full year. Book value per share increased 14% to $543.96, driven by net income and a $661.7 million increase in net unrealized gains on investments, net of taxes. Total invested assets grew to $18.64 billion, and shareholders' equity reached $7.59 billion.

The company recorded $435.5 millionc of favorable development on prior years' loss reserves in 2014, though it also cautioned that this favorable trend should not be relied upon, and it recorded a $13.7 million goodwill impairment related to the Diamond Healthcare reporting unit. The filing also highlights ongoing exposure to asbestos and environmental claims, with A&E net reserves of $287.7 million, and to equity market risk, since equity securities represented 54% of shareholders' equity at year end. Debt to capital was 23%, down from 25% in 2013, and the company reported approximately 8,600 employees.

Key Highlights

  1. Gross premium volume reached $4.81 billion in 2014, up from $3.92 billion in 2013, with Alterra premiums contributing for a full year.
  2. Net income to shareholders was $321.2 million in 2014, up from $281.0 million in 2013; diluted EPS was $22.27 versus $22.48.
  3. The U.S. GAAP combined ratio improved to 95% in 2014 from 97% in 2013, and underwriting profit rose to $177.6 million from $103.0 million.
  4. Book value per share increased 14% to $543.96, supported by a $981.0 million increase in net unrealized investment gains.
  5. Favorable prior-year reserve development of $435.5 million contributed to results, though management cautioned against relying on this trend.
  6. Markel Ventures generated revenues of $838.1 million and net income to shareholders of $9.6 million, which included a $13.7 million goodwill impairment.
  7. Equity securities were 54% of shareholders' equity at year end, creating significant equity price risk.

Financial Statements

FY2014 against FY2013

Line itemFY2014FY2013Change
Revenue$5.13B$4.32B+18.8%
Operating Expenses$4.58B$3.85B+18.9%
Operating Income$557.82M$475.75M+17.3%
Interest Expense$117.44M$114.00M+3.0%
Net Income$321.18M$281.02M+14.3%
EPS (Basic)$22.38$22.57−0.8%
EPS (Diluted)$22.27$22.48−0.9%
Shares Outstanding (Basic)13.98M12.54M+11.5%
Shares Outstanding (Diluted)14.06M12.59M+11.7%

Frequently Asked Questions

  1. How did Markel's underwriting performance change in 2014?

    The U.S. GAAP combined ratio improved to 95% in 2014 from 97% in 2013, and underwriting profit increased to $177.6 million from $103.0 million. The filing attributes the improvement to a lower expense ratio, partly offset by less favorable prior accident years' loss development, and notes that 2013 expenses included $75.1 million of Alterra acquisition-related costs.

  2. What drove the increase in book value per share?

    Book value per share rose 14% to $543.96, primarily due to net income to shareholders of $321.2 million and a $661.7 million increase in net unrealized gains on investments, net of taxes.

  3. What are the main risks highlighted in the filing?

    The filing highlights soft market pricing conditions, reserve uncertainty (including $287.7 million of net A&E reserves), reliance on reinsurers, and equity price risk, since equity securities were 54% of shareholders' equity. A 35% decline in equity prices would reduce shareholders' equity by an estimated 12.8%.

  4. How is the company's capital structure positioned?

    Senior long-term debt and other debt was $2.25 billion, and the debt-to-capital ratio was 23% at year end, down from 25% in 2013. The company had no borrowings outstanding under its $300 million revolving credit facility at December 31, 2014.